Growth Metrics

Protalix BioTherapeutics (PLX) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 31.13%
Dec 31, 2025 9.77%
Sep 30, 2025 -12.17%
Jun 30, 2025 -5.34%
Mar 31, 2025 -1.82%
Dec 31, 2024 27.15%
Sep 30, 2024 17.41%
Jun 30, 2024 16.35%
Mar 31, 2024 11.70%
Dec 31, 2023 -29.09%
Sep 30, 2023 0.26%
Jun 30, 2023 -11.26%
Mar 31, 2023 3.42%
Dec 31, 2022 -7.62%
Sep 30, 2022 0.99%
Jun 30, 2022 -4.42%
Mar 31, 2022 -2.73%
Dec 31, 2021 -1.03%
Sep 30, 2021 -5.14%
Jun 30, 2021 -39.52%
Mar 31, 2021 -19.45%
Dec 31, 2020 26.02%
Sep 30, 2020 -7.24%
Jun 30, 2020 -0.44%
Mar 31, 2020 8.59%
Dec 31, 2019 34.49%
Sep 30, 2019 25.24%
Jun 30, 2019 22.84%
Mar 31, 2019 23.06%
Dec 31, 2018 20.89%
Sep 30, 2018 -6.93%
Jun 30, 2018 13.15%
Mar 31, 2018 4.85%
Dec 31, 2017 2.24%
Mar 31, 2017 14.82%
Dec 31, 2016 9.86%
Sep 30, 2016 17.50%
Jun 30, 2016 -18.14%
Mar 31, 2016 -16.77%
Dec 31, 2015 -13.64%
Sep 30, 2015 11.98%
Jun 30, 2015 9.98%
Mar 31, 2015 -1.69%
Dec 31, 2014 -26.58%
Mar 31, 2014 -15.65%
Dec 31, 2013 -34.01%
Sep 30, 2013 -27.21%
Jun 30, 2013 15.53%